Cargando…
Tropism of Extracellular Vesicles and Cell-Derived Nanovesicles to Normal and Cancer Cells: New Perspectives in Tumor-Targeted Nucleic Acid Delivery
The main advantage of extracellular vesicles (EVs) as a drug carrier system is their low immunogenicity and internalization by mammalian cells. EVs are often considered a cell-specific delivery system, but the production of preparative amounts of EVs for therapeutic applications is challenging due t...
Autores principales: | Oshchepkova, Anastasiya, Markov, Oleg, Evtushenko, Evgeniy, Chernonosov, Alexander, Kiseleva, Elena, Morozova, Ksenia, Matveeva, Vera, Artemyeva, Lyudmila, Vlassov, Valentin, Zenkova, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621453/ https://www.ncbi.nlm.nih.gov/pubmed/34834326 http://dx.doi.org/10.3390/pharmaceutics13111911 |
Ejemplares similares
-
Cytochalasin-B-Inducible Nanovesicle Mimics of Natural Extracellular Vesicles That Are Capable of Nucleic Acid Transfer
por: Oshchepkova, Anastasiya, et al.
Publicado: (2019) -
Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges
por: Oshchepkova, Anastasiya, et al.
Publicado: (2023) -
Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles—A Novel Strategy for Enhancement of the Anti-tumor Immune Response
por: Markov, Oleg, et al.
Publicado: (2019) -
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
por: Markov, Oleg V., et al.
Publicado: (2015) -
Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS(40) Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response
por: Markov, Oleg V., et al.
Publicado: (2022)